Lymphoma
Conditions
Interventions
Observation group:None
Sponsors
Shanghai Ninth People's Hospital,Shanghai JiaoTong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Male or female, aged 18 to 65 (including both 18 and 65); 2.For patients diagnosed with malignant lymphoma, after completing standard treatment in accordance with the diagnosis and treatment guidelines and achieving complete remission (CR), autologous hematopoietic stem cell transplantation was performe; 3.All patients must have given informed consent to this study and have voluntarily signed a written informed consent form by themselves (or their legal representatives);
Exclusion criteria
Exclusion criteria: 1.Pregnant or lactating women who have the ability to reproduce but refuse to take contraceptive measures; 2.History of other malignant tumors except malignant lymphoma, unless the patient's disease has been cured for more than 3 years; 3.Any past or current diseases, treatments, or laboratory abnormalities that may interfere with the research results or affect the patient's full participation in the study, or any conditions that the researcher deems the patient unsuitable to participate in this study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival after transplantation;Changes in ctDNA before and after transplantation; | — |
Countries
China
Contacts
Public ContactJun Shi
Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Outcome results
None listed